Details for Patent: 5,496,804
✉ Email this page to a colleague
Summary for Patent: 5,496,804
| Title: | Method for treating taxol side-effects with G-CSF |
| Abstract: | A method of treating a host using taxol comprising administering granulocyte colony-stimulating factor to the host being treated with taxol. The present inventive method allows for increased levels of taxol to be administered to the host in the treatment of various conditions, particularly with respect to ovarian tumors. |
| Inventor(s): | Reed; Eddie (Germantown, MD), Kohn; Elise (Olney, MD), Sarosy; Gisele (Silver Spring, MD) |
| Assignee: | The United States of America as represented by the Department of Health (Washington, DC) |
| Application Number: | 08/342,797 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,496,804
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,496,804
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2092271 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
